Atlas Trials

Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma

Clinical trial NCT05420597 · UNKNOWN

Trial details

NCT number
NCT05420597
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Laryngeal CancerHypopharyngeal Cancer
Start date
2021-04-07
Primary completion
2024-12-31
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.